Imipramine Clinical Trials

3 actively recruiting trials across 3 locations

▲ +1 trial since August 2026

Also known as: 50-49-7, 5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)propyl)-10,11-dihydro-

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

Wright State University1
VA Office of Research and Development1
Mayo Clinic1

Indications

Cancer3
Actinic Keratosis2
Imipramine2
Photodynamic Therapy2
Recurrent Glioma1

Jacksonville, Florida1 trial

A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial

Mayo Clinic in Florida

N/A

Dayton, Ohio1 trial

The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans

Dayton VA Medical Center, Dayton, OH

Phase 2

Fairborn, Ohio1 trial

The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy

Wright State Physicians

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.